Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, giving promising enhancements across numerous health-related and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, additional dependable option for therapeutic use